Geographical Group Reporting Submission

Cochrane Italy
Claudia De Santis
Cochrane Review: Amyloid‐beta‐targeting monoclonal antibodies for people with mild cognitive impairment or mild dementia due to Alzheimer’s disease
Date
16-04-2026
16-04-2026
No
No
Claudia De Santis
cochrane.italia@ausl.bologna.it
Evidence production
This review is having a significant impact on shaping policy related to this class of drugs. It has already received over 1,600 media mentions across various outlets.